University of Texas Southwestern Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Texas Southwestern Medical Center sits in the top decile of US sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count).

837 total trials 162 currently recruiting 503 completed early-phase tilt top decile by trial count

University of Texas Southwestern Medical Center: 837 sponsored US clinical trials, 162 recruiting.

University of Texas Southwestern Medical Center sponsors 837 registered US clinical trials on ClinicalTrials.gov, 162 of them currently recruiting, and 503 completed. 126 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 9 trials.

Top-decile sponsor footprint

University of Texas Southwestern Medical Center ranks in the top decile of sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 46/100

503 of 608 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

837 total, page 1 of 17

RECRUITING

Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain

NCT03849963

RECRUITING NA

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

NCT07183644

RECRUITING Early Phase 1

Imaging Acetadote Metabolism in Glioblastoma

NCT07387666

RECRUITING NA

Nudging Parental Actions for Youth Suicide Prevention

NCT07383714

RECRUITING NA

Video vs. Direct Laryngoscopy for Less Invasive Surfactant Administration

NCT07426016

RECRUITING Early Phase 1

Ketamine in Severe Traumatic Brain Injury

NCT06062628

RECRUITING NA

RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry

NCT07136363

RECRUITING NA

Examining the Feasibility of Using Pressure Gradient Regulated Automated Cerebral Spinal Fluid Drainage During External Lumbar Drain Trials

NCT07494812

RECRUITING NA

The Return of Cardiovascular Information Trial (RECITE)

NCT07613853

RECRUITING

Non-Invasive ICP Monitoring Study

NCT07113353

RECRUITING NA

HIV Pre-Exposure Prophylaxis (PrEP) Linkage With Immediate Medications in the Emergency Department Study

NCT07462611

RECRUITING Phase 1

Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract Infections

NCT06907199

RECRUITING

FOCUS Bipolar: Families Opening Conversations for Understanding Signs

NCT07622927

RECRUITING NA

IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion

NCT07361874

RECRUITING NA

The Effect of Simulated Burn Injury on Post Exercise Recovery in Hot Environments

NCT07050264

RECRUITING Phase 1

Intraneural Administration of scAAV9/JeT-GAN Into the Vagus Nerve for Patients With Giant Axonal Neuropathy (GAN)

NCT07543991

RECRUITING Phase 1

MTOR Inhibitors in Older Adults

NCT06727305

RECRUITING NA

Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program

NCT07342855

RECRUITING

Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study

NCT07196839

RECRUITING Phase 2

A Polypill for Acute Coronary Syndrome

NCT07032389

RECRUITING NA

Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder

NCT06025734

RECRUITING Phase 2

Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)

NCT07313241

RECRUITING NA

Teen Recovery Through Inspiration, Support, and Empowerment

NCT07170657

RECRUITING Phase 1

Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)

NCT07139990

RECRUITING NA

IEEM-Heat and Heart Failure

NCT06961929

RECRUITING Early Phase 1

Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung

NCT06712745

RECRUITING Phase 3

Home-based Cardiac Rehabilitation in Heart Failure

NCT06349941

RECRUITING Phase 1

Periprostatic Neurolysis in Prostate Cancer

NCT07100847

RECRUITING

IEEM- Work:Rest Cycles in Burn Survivors- Humidity

NCT06966336

RECRUITING NA

Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes

NCT06593314

RECRUITING NA

A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections

NCT06940622

RECRUITING

The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services

NCT07292792

RECRUITING Phase 2

Escitalopram in Asthma Patients With Frequent Exacerbation

NCT06216535

RECRUITING NA

UTSW NORC Pilot Spinal Cord Injury Dietary Program

NCT06924177

RECRUITING NA

Phosphate Assessment in Chronic Kidney Disease Patients Study

NCT07368946

RECRUITING NA

Leg Heating in Pregnant Women With Obesity

NCT06932250

RECRUITING Phase 1

Study of IOMAB-ACT Followed by CAR-T Cell Therapy for Patients Relapsed or Refractory (Diffuse Large B-cell Lymphoma

NCT06768905

RECRUITING NA

Development and Validation of Virtual Laparoscopic Hiatal Hernia Simulator

NCT06974383

RECRUITING Phase 2

Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer

NCT06601296

RECRUITING NA

Recovery Through Inspiration, Support, and Empowerment

NCT07051200

RECRUITING NA

Empowering Perinatal Adolescents Through Writing

NCT06771817

RECRUITING NA

HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy

NCT06919419

RECRUITING Phase 1

Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease

NCT06158620

RECRUITING Phase 2

Ligufalimab and Cadonilimab in Advanced Liver Cancers

NCT06789848

RECRUITING Phase 2

Tailored Exercise Training Study Among Adults With HFpEF

NCT07223242

RECRUITING NA

Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury

NCT06467708

RECRUITING NA

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

NCT06593327

RECRUITING

Impact of Extreme Heat on Myocardial Blood Flow and Flow Reserve in Young and Older Adults

NCT06842784

RECRUITING NA

Cardiovascular Responses in Burn Survivors During Exercise

NCT06709781

RECRUITING

ET Stigma Response to Tremor Suppression

NCT07430761

Page 1 of 17 Next →

Phase Distribution

PhaseTrial count
Phase 1 106
Phase 2 122
Phase 3 28
Phase 4 98

What is open in the University of Texas Southwestern Medical Center pipeline

162 recruiting of 837 indexed (19% open); 503 completed (60%).

Phase mix: 126 late (III/IV) vs 228 early (I/II) (early-phase heavy).

Top condition: Hypertension (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Texas Southwestern Medical Center: open-pipeline peers nationwide

Peers matched on 837 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of Texas Southwestern Medical CenterUniversity of UtahUniversity of ChicagoIndiana UniversityDana-Farber Cancer InstituteCalifornia Polytechnic State University-San Luis ObispoPhoenix Children's HospitalAnn & Robert H Lurie Children's Hospital of ChicagoVanderbilt University Medical Center
University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 837 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this University of Texas Southwestern Medical Center page

837 registered trials is a research-attention snapshot, not an endorsement of University of Texas Southwestern Medical Center or any single study.

  • 162 of University of Texas Southwestern Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hypertension is the condition University of Texas Southwestern Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Texas Southwestern Medical Center pipeline card: 837 registered trials from official public datasets.Report a data error.